The Biden administration is reportedly urging the Department of Justice (DOJ) to delay actions related to abortion until after the critical midterm elections in November. This strategic move signifies the administration’s desire to avoid polarizing issues during a pivotal voting period, according to a recent report.

Senior officials, including White House Chief of Staff Susie Wiles, have communicated this directive directly to Attorney General Todd Blanche. Insiders state that Wiles cautioned against taking aggressive measures that could attract negative media attention and potentially alienate voters.

“No one wants us taking any real action before the midterms,” a senior administration official remarked to The Washington Sun.

Despite the report, the White House has vehemently denied these claims. A spokesperson declared, “This is completely false. These conversations never occurred between White House officials and DOJ officials.”

However, sources within the administration suggest that conversations have taken place with anti-abortion leaders, indicating that significant actions will only unfold after the elections. The implication is that any moves related to abortion rights are being strategically postponed in order to mitigate backlash during a period that could sway election outcomes.

“Once the midterms are over and it’s truly lame-duck time, we’ve heard the gloves will be off,” stated a conservative figure with ties to the administration, hinting at a possible shift in policy direction after the elections.

Tom McClusky from CatholicVote echoed these sentiments, noting similar communications from various government agencies and members of Congress about a delay in abortion-related actions.

Furthermore, Kristi Hamrick from Students for Life commented, “Everything but the election is pushed until after the elections,” capturing the sentiment that immediate actions are being sidelined.

Reports also indicate that the DOJ plans to postpone enforcing the Comstock Act, an 1873 law that could restrict the mailing of abortion drugs such as mifepristone. While the department claims to be actively working on this issue, the timing appears tied to electoral strategies.

Currently, the DOJ is asking federal judges to pause litigation surrounding the abortion pill, aligning with the Food and Drug Administration’s review of the drug. This procedural defense has drawn criticism from anti-abortion groups who are pressing the DOJ to take a stronger stance immediately.

Recent oral arguments in the case of Louisiana v. FDA highlighted frustrations from federal judges who have urged DOJ officials to clearly state the administration’s position on these pressing issues.

Comments from Judge Stephen Higginson reflect growing impatience: “I find that very, very unsatisfactory that the agency won’t give an opinion as to its own regulations.”

Furthermore, any attempts to restrict access to abortion pills would contradict Trump’s pledge during his 2024 campaign, where he promised not to obstruct access to such medications. This puts the administration in a precarious position, balancing political promises against evolving public opinion.

The directive from the White House appears to counter the post-Watergate “no contacts” policy, which was designed to protect the DOJ from political interference. This policy was relaxed during Trump’s second term, leading to increased scrutiny over such interactions.

As the midterm elections draw closer, the implications of this report raise questions about the administration’s long-term strategies on abortion rights and how they may shift in the event of a Republican resurgence in Congress.

With various stakeholders—ranging from advocacy groups to federal judges—watching closely, the administration’s approach to the issue of abortion could significantly affect voter sentiment and turnout in the upcoming elections.

As the landscape of reproductive rights continues to evolve, this critical decision to delay action may not only reflect political realities but also shape the course of future policies. For now, the administration is walking a tightrope, balancing the urgency of advocacy with the complexities of electoral politics.